Monthly Archives: October 2019

BriaCell Announces Voting Results of the Special Meeting of Shareholders
October 24, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, October 24, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Closing of Non-Brokered Private Placement of $568,444
October 15, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, October 15, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Therapeutics Corp. to File Amendment to Management Information Circular
October 8, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, October 8, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT™ in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer
October 7, 2019

• Patient dosing has begun in the Phase I/IIa study evaluating the anti-tumor effects of ...

BriaCell Therapeutics Corp. to Clarify Record Date
October 1, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Note from Chairman of BriaCell Therapeutics – October is Breast Cancer Awareness Month
October 1, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Skip to content